R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

NCT00005041 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: tipifarnib

Sponsor

NYU Langone Health

Collaborators

[object Object]